Botulinum Toxin Daxxify Gets FDA Nod for Cervical Dystonia Botulinum Toxin Daxxify Gets FDA Nod for Cervical Dystonia

The FDA grants daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) a therapeutic indication for treatment of cervical dystonia in adults.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news